Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia

Journal of General Virology

Volumn 79, Issue 8, 1998, Pages 1971-1976

  Gill, Dilbinder K ^a,b   Bible, Jon M ^a   Biswas, Chandrima ^a   Kell, Barbara ^a   Best, Jennifer M ^a   Punchard, Neville A ^b   Cason, John ^a  

^a Department of Infection   (United Kingdom)

^b UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CELL LINE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031847159     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-8-1971     Document Type: Article

References (25)

1. Bavin, P., Giles, J. A., Deery, A., Crow, P., Griffiths, P., Emery, V. C. & Walker, P. (1993). Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high-grade cervical disease in a population presenting with a mildly dyskaryotic smear report. British Journal of Cancer 67, 602-605.
2. Benton, C., Shahidullah, H. & Hunter, J. A. A. (1992). Human papillomavirus in the immunosuppressed. Papillomavirus Report 3, 23-26.
3. Biswas, C., Kell, B., Mant, C., Jewers, R. J., Cason, J., Muir, P., Raju, K. S. & Best, J. M. (1997). Detection of human papillomavirus type 16 early gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. Journal of Clinical Microbiology 35, 1560-1564.
4. Borysiewicz, L. K., Fiander, A., Nimako, M., Man, S., Wilkinson, G. W. G., Westmoreland, D., Evans, A. S., Adams, M., Stacey, S. N., Boursnell, M. E. G., Rutherford, E., Hickling, J. K. & Inglis, S. C. (1996). A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical carcinoma. Lancet 347, 1523-1527.
5. Cason, J. (1996). Perinatal acquisition of cervical cancer associated human papillomaviruses. British Journal of Obstetrics & Gynaecology 103, 853-858.
6. Cason, J., Patel, D., Naylor, J., Lunney, D., Shepherd, P. S., Best, J. M. & McCance, D. J. (1989). Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. Journal of General Virology 70, 2973-2987.
7. Cavuslu, S., Starkey, W. G., Kaye, J. N., Biswas, C., Mant, C., Kell, B., Rice, P., Best, J. M. & Cason, J. (1996). Detection of human papillomavirus type-16 (HPV-16) DNA utilizing microtitre-plate based amplification reactions and a solid-phase enzyme-immunoassay detection system. Journal of Virological Methods 58, 59-69.
8. Cavuslu, S., Goodlad, J., Hobbs, C., Connor, A. M., Raju, K. S., Best, J. M. & Cason, J. (1997). Relationship between human papillomavirus infection and over-expression of p53 protein in cervical carcinomas and lymph-node metastases. Journal of Medical Virology 53, 111-117.
9. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. & Stanley, M. A. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology 102, 768-774.
10. Cusick, J., Terry, G., Ho, L., Hollingworth, T. & Anderson, M. (1992). Human papillomavirus type 16 DNA in cervical smears as a predictor of high-grade cervical intra-epithelial neoplasia. Lancet 339, 959-960.
11. Denzoit, F. & Lang, R. (1986). Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 89, 271-277.
12. de Villiers, E.-M. (1992). Laboratory techniques in the investigation of human papillomavirus infection. Genitourinary Medicine 68, 50-54.
13. Frazer, I. H. & Tindle, R. W. (1992). Cell-mediated immunity to papillomaviruses. Papillomavirus Report 3, 53-58.
14. Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W. & Schneide, W. J. (1985). Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annual Review of Cellular Biology 1, 1-39.
15. Halbert, C. L. & Galloway, D. A. (1988). Identification of the E5 open reading frame of human papillomavirus type 16. Journal of Virology 62, 1071-1075.
16. Kell, B., Jewers, R. J., Cason, J., Pakarian, F., Kaye, J. N. & Best, J. M. (1994). Detection of E5 oncoprotein in human papillomavirus type-16 positive cervical scrapes using antibodies raised to synthetic peptides. Journal of General Virology 75, 2451-2456.
17. IARC (1995). Epidemiology of infection. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Human Papillomaviruses, pp. 60-65. Lyon: International Agency for Research on Cancer, World Health Organization.
18. Luxton, J. C., Rose, R. C., Coletart, T., Wilson, P. & Shepherd, P. S. (1997). Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. Journal of General Virology 78, 917-923.
19. Mant, C., Kell, B., Best, J. M. & Cason, J. (1997). Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types -6,-11, -16, -18, -31 and -33. Journal of Virological Methods 66, 169-178.
20. Oelze, I., Kartenbeck, J., Crusius, K. & Alonso, A. (1995). Human papillomavirus type 16 affects cell-cell communication in an epithelial cell line. Journal of Virology 69, 4489-4494.
21. Seedorf, K., Krammer, G., Durst, M., Suhai, S. & Rowekamp, W. G. (1985). Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
22. Shepherd, P. S., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Luxton, J. C. (1996). Proliferative T-cell responses to human papillomavirus type 16 peptides in patients with cervical dysplasia. Journal of General Virology 77, 593-602.
23. Stoler, M., Rhodes, C., Whitbeck, A., Wolinsky, S., Chow, L. & Broker, T. (1992). Human papillomavirus type 16 gene expression in cervical neoplasias. Human Pathology 23, 117-128.
24. Tsukui, T., Hildesheim, A., Schiffman, M. H., Lucci, J., III, Contois, D., Lawler, P., Rush, B. B., Lorincz, A. T., Corrigan, A., Burk, R. D., Qu, W., Marshall, M. A., Mann, D., Carrington, M., Clerici, M., Shearer, G. M., Carbone, D. P., Scott, D. R., Houghten, R. A. & Berzofsky, J. A. (1996). Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Research 56, 3967-3974.
25. zur Hausen, H. (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics in Microbiology and Immunology 186, 131-156.